Zhaohui Su: Adaptive and Bayesian Designs Are Increasingly Gaining Traction in the Research Landscape

Zhaohui Su, VP of Biostatistics at Ontada, shared a post on LinkedIn:

“This paper by Danila Azzolina and colleagues presents an analysis of over 348,000 ClinicalTrials.gov records, revealing a clear and encouraging trend: novel clinical trials, particularly Adaptive Designs and Bayesian Designs, are increasingly gaining traction in the research landscape.

These innovative approaches are expanding beyond oncology into fields such as neuroscience, rare diseases, and other high-need areas, bolstered by regulatory guidance and improved analytics. This trend signals a positive shift in the field, as it embraces smarter, more flexible, and patient-centered methodologies that can accelerate learning and deliver better therapies to patients more quickly.”

Title: Insights into the adoption of innovative clinical trials across therapeutic areas using clinical trials registry data and large Language models

Authors: Danila Azzolina, Vittorio Scisciola, Luca Vedovelli, Domenico Iervolino, Mohd Rashid Khan, Rosanna Irene Comoretto, Martino Belvederi Murri, Dario Gregori

Read the article.

Other articles about Zhaohui Su on OncoDaily.